Home > PE Ratio > ANUH PHARMA

ANUH PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of ANUH PHARMA is 18.79.

Share Price ₹221.4Dec 11,2024
Market Cap ₹1,109.2 Cr
Earnings-TTM₹59.0 CrTTM-Standalone Results
Price/Earnings18.79xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results
ANUH PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of ANUH PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ANUH PHARMA is calculated as :

Current Market Cap [ ₹1,109.2 Cr] as on Dec 11,2024

(/) Earnings [ ₹59.0 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 18.79x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ANUH PHARMA , the investors are currently willing to pay 18.79 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ANUH PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ANUH PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of ANUH PHARMA


PE Ratio Performance Analysis for ANUH PHARMA

- ANUH PHARMA 's latest p/e ratio is 18.79x.

- ANUH PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 14.35x.

- ANUH PHARMA 's operated at median p/e ratio of 14.09x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ANUH PHARMA 's p/e ratio peaked in Mar2024 at 20.49x.

- ANUH PHARMA 's p/e ratio hit its five-year low in Mar2020 of 10.21x.


How does ANUH PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ANUH PHARMA 59.0218.791,109.2
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.10435,407.0
CIPLA LTD4,485.2226.18117,443.0
DR REDDYS LABORATORIES LTD5,406.8019.11103,338.0
ZYDUS LIFESCIENCES LTD4,298.9023.0999,244.9
DIVIS LABORATORIES LTD1,836.0085.78157,489.0
MANKIND PHARMA LTD2,124.8649.46105,098.0
TORRENT PHARMACEUTICALS LTD1,802.0063.38114,202.0
LUPIN LTD2,651.9436.9798,055.1
AUROBINDO PHARMA LTD3,598.8319.7871,188.9
ABBOTT INDIA LTD1,284.6647.7561,336.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ANUH PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.79x
Max industry PE 85.78x
Median industry PE 36.97x
Average industry PE 39.04x



You may also like the below Video Courses